(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Quarter results tomorrow
(bmo 2024-04-28)
Expected move: +/- 14.77%
Live Chart Being Loaded With Signals
Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer...
Stats | |
---|---|
Dagens volum | 27 122.00 |
Gjennomsnittsvolum | 2.41M |
Markedsverdi | 22.02M |
EPS | $0 ( 2024-04-26 ) |
Neste inntjeningsdato | ( $0 ) 2024-04-28 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.19 |
ATR14 | $0.0490 (0.94%) |
Volum Korrelasjon
Aptorum Group Ltd Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
TSHA | 0.938 |
CYTO | 0.935 |
NAKD | 0.934 |
TNGX | 0.934 |
AHPI | 0.93 |
TRIT | 0.929 |
SIRI | 0.928 |
IMV | 0.924 |
JAGX | 0.923 |
TENX | 0.923 |
10 Mest negative korrelasjoner | |
---|---|
PUCK | -0.948 |
THCPU | -0.947 |
OVLY | -0.945 |
BRACU | -0.942 |
XM | -0.939 |
NCAC | -0.935 |
WFRD | -0.935 |
INOD | -0.935 |
TGTX | -0.934 |
MCAA | -0.933 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Aptorum Group Ltd Korrelasjon - Valuta/Råvare
Aptorum Group Ltd Økonomi
Annual | 2022 |
Omsetning: | $1.30M |
Bruttogevinst: | $80 065.00 (6.18 %) |
EPS: | $-14.89 |
FY | 2022 |
Omsetning: | $1.30M |
Bruttogevinst: | $80 065.00 (6.18 %) |
EPS: | $-14.89 |
FY | 2021 |
Omsetning: | $1.54M |
Bruttogevinst: | $81 854.00 (5.31 %) |
EPS: | $-7.94 |
FY | 2020 |
Omsetning: | $911 509 |
Bruttogevinst: | $-103 514 (-11.36 %) |
EPS: | $2.24 |
Financial Reports:
No articles found.
Aptorum Group Ltd
Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A. The company is also developing ALS-2/3 for the treatment of gram+ve bacterial infections; RPIDD, a pathogen molecular diagnostic; NativusWell DOI (NLS-2), a dietary supplement; NLS-1 for the treatment of endometriosis; DLS-1+2 to treat NSCLC with mutation; DLS-3, an autoimmune small molecule; and CLS-1 for the treatment of obesity. Its pipeline products enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platforms for treatment of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. In addition, it operates a medical clinic. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.